Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R Pérez-Egea
Preclinical and Clinical Characterization of the Selective 5-HT1Areceptor Antagonist DU-125530 for Antidepressant Treatment
British Journal of Pharmacology
Pharmacology
Related publications
Preclinical Sex Differences in Depression and Antidepressant Response: Implications for Clinical Research
Journal of Neuroscience Research
Molecular Neuroscience
Cellular
Treatment of Hypertension With Ketanserin, a New Selective 5-Ht2 Receptor Antagonist.
BMJ
5-Ht2b Receptors Are Required for Serotonin-Selective Antidepressant Actions
Molecular Psychiatry
Psychiatry
Molecular Neuroscience
Mental Health
Molecular Biology
Cellular
Antidepressant and Anxiolytic Effects of Selective 5-Ht6 Receptor Agonists in Rats
Psychopharmacology
Pharmacology
Clinical Importance of Long-Term Antidepressant Treatment
British Journal of Psychiatry
Medicine
Psychiatry
Mental Health
The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder
Expert Opinion on Drug Discovery
Drug Discovery
Selective Activation of Postsynaptic 5-Ht1a Receptors Induces Rapid Antidepressant Response
Neuropsychopharmacology
Psychiatry
Mental Health
Pharmacology
AE9C90CB: A Novel, Bladder-Selective Muscarinic Receptor Antagonist for the Treatment of Overactive Bladder
British Journal of Pharmacology
Pharmacology
Screening of 5-HT1AReceptor Antagonists Using Molecularly Imprinted Polymers
Journal of the American Chemical Society
Biochemistry
Colloid
Catalysis
Chemistry
Surface Chemistry